Building a Foundation: Understanding CD27 Deficiency

If you have recently learned that you or your child has CD27 deficiency, you are likely experiencing a mix of relief at finally having an answer and significant anxiety about what this rare diagnosis means. This condition is an inborn error of immunity (a genetic disorder that affects how the immune system functions), and it is exceptionally rare ^[1]. While researchers have documented roughly two dozen cases in detail, the exact total number of individuals identified worldwide remains uncertain ^[1][2][3].

Because it is so rare, many families spend years searching for answers while facing unusual or severe infections. Validating that journey is important; your experience of a “long road” to diagnosis is a common reality for those with ultra-rare immune disorders ^[4][5].

The Role of CD27: A Communication Bridge

To understand this condition, it helps to think of the immune system as a massive communication network. CD27 is a protein found on the surface of several types of immune cells, most notably T-cells (cells of the immune system that hunt down virus-infected cells) ^[6].

In a healthy immune system, CD27 acts like a communication bridge. When a T-cell encounters a virus, CD27 connects with another protein called CD70. This connection—or “ligation”—sends a powerful signal to the T-cell, supporting its activation, expansion, survival, and memory of the virus for the future ^[7][8].

Without functional CD27:

• Impaired Activation: T-cells may recognize a virus, but they do not receive the necessary signaling boost to mount a strong, coordinated attack ^[6].
• Weakened Memory: The immune system struggles to create robust memory T-cells, which are needed for long-term protection against viruses ^[9][10].
• B-cell issues: CD27 also plays a role in how B-cells (cells that make antibodies) mature. This is why some people with this deficiency have low antibody levels (hypogammaglobulinemia) or struggle with common infections like ear and sinus infections ^[11][3].

The Specific Challenge of EBV

The most significant challenge in CD27 deficiency is how the body handles the Epstein-Barr Virus (EBV). EBV is extremely common; most people catch it at some point, often causing nothing more than “mono” (infectious mononucleosis).

However, in someone with CD27 deficiency, the T-cell responses are particularly impaired when it comes to EBV ^[9]. Because the T-cells cannot effectively clear the virus, EBV can stay active in the body much longer than it should. This persistent viral activity can lead to lymphoproliferation—a state where immune cells grow out of control—which increases the risk of serious complications like lymphoma ^[3][12].

Genetics and Inheritance

CD27 deficiency is an autosomal recessive condition. This means a person must inherit two pathogenic (disease-causing) copies of the TNFRSF7 gene (the gene that provides instructions for making CD27)—one from each parent—to have the condition ^[1][2].

• Carriers: Parents typically have one working copy and one broken copy. They are called carriers and usually have no symptoms because one working gene is enough for a healthy immune system ^[1].
• The 25% Rule: For two carrier parents, there is a 25% chance with each pregnancy that the child will inherit both broken genes and have CD27 deficiency.
• Genetic Counseling: Families should undergo genetic counseling to discuss reproductive risks, variant interpretation, and testing for siblings or other relatives.

Why Does the Condition Look Different in Everyone?

One of the most confusing aspects of CD27 deficiency is its phenotypic diversity—the fact that it can look very different from person to person. Even within the same family, siblings who have the exact same genetic mutation can have wildly different experiences ^[2].

For example, an illustrative published report documented one family where four siblings developed Hodgkin lymphoma, while two other siblings with the same deficiency had no signs of cancer at all ^[2]. Researchers are still studying why this happens, but it likely involves a combination of environmental factors (like when a person is first exposed to EBV) and other minor genetic differences ^[3]. While HLH or lymphoma is a serious possibility, it is not an inevitable outcome.

Because the condition is so unpredictable, your care team will focus on close, personalized monitoring rather than assuming your path will be exactly like someone else’s. While the risks associated with EBV are serious, a diagnosis is the first step toward a management plan that can include antiviral strategies and regular screenings to catch any issues early.

For information on what symptoms to watch for and when to seek immediate care, please refer to the Symptoms and Warning Signs page.